Alzheimers

FDA grants priority review for Alzheimer's drug Lecanemab, say Eisai, Biogen

The FDA accepted Eisai's supplemental Biologics License Application for the drug, supporting the transition from the accelerated approval granted in January

Why a new Alzheimer’s drug is having a slow US debut

Two big factors behind the slow debut, experts say, are scant insurance coverage and a long setup time needed by many health systems

Alzheimer's: Conscious efforts and lifestyle changes will help manage risk factors

The modifiable risk factors include high blood pressure, diabetes, smoking, excessive alcohol consumption, obesity, depression, physical inactivity, impaired hearing, impaired vision, lower education levels, low levels of social contact, and air pollution

Chris Hemsworth is at high risk of developing Alzheimer's, says, 'I just didn't want to manipulate it and overdramatise'

Thor star emphasised that this finding doesn’t mean that he has been diagnosed with Alzheimer's, and neither does it mean that he will definitely develop the condition.

5 myths about Alzheimer's disease

With age, many people become more forgetful and occasionally lose or misplace things

Earlier Alzheimer's is diagnosed, better the chance of the medicines working says health expert

A promising avenue for early diagnosis is detecting biomarkers — biological signatures of lesions caused by the illness.

Study finds arthritis-treating drugs tocilizumab, sarilumab help reduce COVID-19 deaths

The analysis included information on 10,930 patients, of whom 6,449 were randomly assigned to receive interleukin-6 inhibitors and 4,481 to receive usual care or placebo.

Biogen has until 2030 to prove its new controversial Alzheimer's drug works

Aduhelm is a $56,000-a-year drug that is supposed to slows down the brain-destroying disease.

In her debut novel, Meera Rajagopalan explores a woman's fading memory through her satirical journal entries

For Rajagopalan, the diary entries become a clever medium to bring home the intrigue of reading the accounts of an unreliable narrator, who might or might not have lived through the experiences that she records or understood those subjects that she claims to know all about.

Daily intake of cheese, wine linked to decrease in risk of age-related cognitive decline, reveals study

The dietary intakes of the participants of this study, however, were self-reported and not clinically supervised or controlled